MEDA Pharma GmbH & Co. KG
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1919-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.medapharma.de
Azelastine Allergen Chamber - Onset of Action Study
- Conditions
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 84
- Registration Number
- NCT06126952
- Locations
- 🇨🇦
Cliantha Research, Mississauga, Ontario, Canada
Real-world Evidence Study on Cystistat
- Conditions
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 74
- Registration Number
- NCT05544695
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Dymista Allergen Chamber - Onset of Action Study
- Conditions
- First Posted Date
- 2020-12-03
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 216
- Registration Number
- NCT04652245
- Locations
- 🇨🇦
Cliantha Research, Mississauga, Ontario, Canada
DYmista NAsal Spray in CHInese Patients
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2022-02-22
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 900
- Registration Number
- NCT03599791
- Locations
- 🇨🇳
Investigational Site 3, Tianjin, Tianjin, China
🇨🇳Investigational Site 1, Tianjin, Tianjin, China
🇨🇳Investigational Site 2, Tianjin, Tianjin, China
MP-AzeFlu Allergen Chamber - Onset of Action Study
- First Posted Date
- 2016-12-28
- Last Posted Date
- 2022-02-22
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 82
- Registration Number
- NCT03004131
- Locations
- 🇨🇦
Inflamax Research, Mississauga, Ontario, Canada
Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)
- First Posted Date
- 2011-10-17
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 221
- Registration Number
- NCT01453179
- Locations
- 🇩🇪
Medical Department of Otto-von-Guericke-University Magdeburg, University Clinic for Dermatology and Venerology, Magdeburg, Germany
🇦🇹Medical University Vienna, Department for General Dermatology, Vienna, Austria
🇩🇪Medical Practice, Münster, Germany
Tepilta® Versus Oxetacaine, Antacids and Placebo
- Conditions
- Interventions
- First Posted Date
- 2011-04-18
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 40
- Registration Number
- NCT01336530
- Locations
- 🇦🇹
Landeskrankenhaus Feldkirch, Feldkirch, Austria
🇩🇪Strahlentherapie Coesfeld, Coesfeld, Germany
🇦🇹Universitätsklinik für Strahlentherapie-Radioonkologie, Innsbruck, Austria
Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg
- Conditions
- Interventions
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 44
- Registration Number
- NCT01256086
- Locations
- 🇺🇸
University of Wisconsin, Madison, Wisconsin, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
🇺🇸University of Florida, Gainesville, Florida, United States
Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays
- Conditions
- Interventions
- First Posted Date
- 2010-09-03
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 30
- Registration Number
- NCT01194622
- Locations
- 🇩🇪
ClinPharmCologne, Cologne, NRW, Germany
Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays
- Conditions
- Interventions
- First Posted Date
- 2010-08-30
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 30
- Registration Number
- NCT01190852
- Locations
- 🇩🇪
ClinPharmCologne, Cologne, NRW, Germany